Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

ADAMTS-13 Activators

A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a group of enzymes known for their role in extracellular matrix remodeling, angiogenesis, and various signaling pathways. ADAMTS-13, in particular, plays a critical role in cleaving von Willebrand Factor (vWF), a large glycoprotein that is essential in hemostasis. The activity of ADAMTS-13 is tightly regulated and is influenced by factors like shear stress, biochemical interactions with substrates or inhibitors, and the local microenvironment. The enzyme is synthesized as a zymogen and is activated following specific cleavages and interactions with co-factors. Furthermore, various signaling pathways such as TGF-β, Notch, and PDGF have been implicated in influencing the expression and activity of ADAMTS-13, establishing the enzyme as a pivotal point in a complex signaling network.

ADAMTS-13 activators belong to a class of molecules designed to enhance the enzymatic activity of ADAMTS-13. These can be peptides, small molecules, or other bioactive compounds that either directly interact with the enzyme to increase its activity or indirectly influence pathways to facilitate the enzyme's function. For instance, some activators might stabilize the ADAMTS-13 protein, thereby increasing its half-life and functional availability. Others could act through epigenetic mechanisms to upregulate the gene expression of ADAMTS-13. Yet another subgroup could indirectly boost ADAMTS-13 activity by inhibiting counteracting pathways or enzymes. Some molecules like reactive oxygen species (ROS) scavengers aim to create an optimal redox environment, facilitating better enzymatic performance. In summary, ADAMTS-13 activators are a diverse class of chemicals that act through various intricate mechanisms to modulate the activity of this key enzyme.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

An HDAC inhibitor that may alter the epigenetic landscape to facilitate ADAMTS-13 gene expression.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

As a TGF-β inhibitor, this molecule might promote ADAMTS-13 activity by preventing downregulation through TGF-β pathways.

GM 6001

142880-36-2sc-203979
sc-203979A
1 mg
5 mg
$77.00
$270.00
55
(1)

An MMP inhibitor that may help maintain the ECM substrates available for ADAMTS-13 activity.

N-Acetyl-L-cysteine

616-91-1sc-202232
sc-202232A
sc-202232C
sc-202232B
5 g
25 g
1 kg
100 g
$34.00
$74.00
$270.00
$114.00
34
(1)

As a reactive oxygen species (ROS) scavenger, this molecule might activate ADAMTS-13 by reducing oxidative stress that could impair its activity.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

An Nrf2 activator that may influence ADAMTS-13 activity under conditions of oxidative stress.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

As a tyrosine kinase inhibitor, it could influence the signaling pathways that regulate ADAMTS-13.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

A gamma-secretase inhibitor that could indirectly affect ADAMTS-13 expression or activity by interfering with Notch signaling.